AeroRx Therapeutics, Inc., a clinical-stage biopharmaceutical company developing proprietary nebulized combination therapies for chronic respiratory diseases, today announced the presentation of ...
Triple therapy for COPD, vs ICS/LABA therapy, was independently associated with ischemic heart disease, heart failure, arrhythmia, and atrial fibrillation/flutter. Cardiovascular events in patients ...
These are the top-line results from the global Phase 3 MIRANDA clinical trial (NCT06040086), which tested a 300 mg dose of tozorakimab once every two weeks against a placebo, on top of standard of ...
The findings provide further support of recommendations in the clinical guidelines to favor one therapy over the other. Patients with chronic obstructive pulmonary disease (COPD) being treated with ...
Researchers argued GPs commonly use triple therapy with inhaled corticosteriods, beta-agonists and antimuscarinics for COPD ‘with only limited scientific support' - but that their study supported the ...
Triple therapy in COPD significantly improves lung function vs LAMA monotherapy, LABA/LAMA, and ICS/LABA, although evidence showing this is often low quality. Triple therapy is likely effective, safe, ...
Please provide your email address to receive an email when new articles are posted on . The single inhaler combined budesonide, glycopyrrolate and formoterol fumarate. The risk for cardiopulmonary ...
GSK's severe asthma therapy Nucala could find a new lease of life as a treatment for chronic obstructive pulmonary disease (COPD) after showing a clear benefit in a phase 3 trial. The headline result ...
Please provide your email address to receive an email when new articles are posted on . Two doses of budesonide/glycopyrrolate/formoterol fumarate decreased the risk ...
The maintenance inhalers available for obstructive lung disease are long-acting beta-agonists (LABAs), long-acting muscarinic antagonists (LAMAs), and inhaled corticosteroids (ICSs). We use all three ...
There are lots of treatment options for genetic COPD (chronic obstructive pulmonary disease), a type of COPD caused by a deficiency of alpha-1 antitrypsin (alpha-1), a protein that helps protect the ...
Nebuliser use in COPD is highest in severe cases, reflecting worsening symptoms, frequent exacerbations, and the need for ...
Sommige resultaten zijn verborgen omdat ze mogelijk niet toegankelijk zijn voor u.
Niet-toegankelijke resultaten weergeven